Loading…
Each decision rolls up every audited claim behind one longevity question — what each creator said, how it stacks up against the literature, and the verdict.
Our read is that taking metformin is well supported, particularly for individuals with metabolic health concerns, though its broader longevity benefits remain uncertain.
Our read is that taking rapamycin is Well Supported for longevity, with evidence suggesting lifespan extension and immune benefits, though potential side effects and optimal dosing require careful consideration.
Our read is that GLP-1 receptor agonists are a well-supported intervention for specific metabolic conditions, but their broader application and long-term implications remain under scrutiny.
Our read is that semaglutide may be a well-supported option for weight management and associated health benefits, particularly for individuals who have maximized lifestyle modifications, but it comes with notable risks and considerations.
Our read is that PCSK9 inhibitors are a well-supported option for lowering cardiovascular risk, particularly in specific patient populations.
Our read is that taking aspirin is partially supported for specific therapeutic uses, but its role in general longevity and primary prevention is increasingly questioned.
Our read is that taking tirzepatide is partially supported, particularly for individuals with metabolic dysfunction or obesity, but requires careful monitoring and consideration of potential side effects.
Our read is that ezetimibe is a well-supported intervention for lowering cholesterol and reducing cardiovascular risk, particularly when combined with other therapies.
Our read is that taking nicotine is partially supported, with experts suggesting safer delivery methods and potential cognitive benefits, but also highlighting significant risks associated with certain forms.
Our read is that taking acarbose is well supported for longevity benefits.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.
No expert claims captured yet — this verdict will fill in as we index more sources.